That's News

By Kate Anastas
Wednesday, May 26, 2021

Bridging the Gap Between Physical and Virtual Care

During the pandemic, telehealth visits increased in popularity as more patients sought care from the privacy of their own homes. But lacking during these virtual physician visits are necessary blood work, tests and imaging services to make a proper diagnosis. Telemedicine can’t help with all illnesses and conditions — but it’s finding its own form of practice extenders.

Ambulnz, a leading medical mobility and transportation service company, recently announced an agreement to merge with Motion Acquisition Corp. The Board of Directors of Ambulnz and Motion unanimously approved the merge, and the combined company will be known as DocGo.

According to the cofounder and CEO of DocGo, Stan Vashovsky, the rebranding represents DocGo’s mission to “[take] traditional health care beyond the walls of hospitals and clinics and [offer] in-home healthcare services at affordable price points to the broader community.” DocGo will deliver quality, non-critical healthcare services to patients in their homes, including wound care, vaccinations and diagnostic testing. The company also offers transparency with real-time vehicle location and accurate estimated arrival times. DocGo currently operates in 26 U.S. states and the U.K.

Innovative Technology to Assist Infant Feeding Wins Pediatric Medical Device Competition

Innara Health’s new biofeedback device, designed to help premature infants learn to feed, was recently recognized by the National Capital Consortium for Pediatric Device Innovation as one of six awardees in its annual “Make Your Medical Device Pitch for Kids!” competition.

Premature babies rely on feeding tubes for critical nutrition during their first days of life. However, tube feeding can make the transition to breast or bottle difficult, which often prolongs an infant’s stay in the NICU. Innara Health, a neonatal medical device company, created a solution: the Ntrainer.

The Ntrainer is the only FDA-cleared medical device that helps premature infants learn to feed by mouth. The system uses gentle pulse therapy delivered through a pacifier-enabled handset to entrain an infant’s oral motor skills. Along with being nationally recognized, Innara Health will also share in $250,000 of grants funded by the FDA in support of its endeavors.

AAP Affirms Position Statement in Favor of Appropriate Care for Transgender Pediatric Patients

Recent legislation in the United States has attempted to restrict or criminalize standard-of-care treatment for transgender and gender-diverse pediatric patients. In light of the proposed policies, the American Academy of Pediatrics affirmed its longtime support for gender-affirming care for these patients. Such care follows the Endocrine Society’s Clinical Practice Guidelines on the Endocrine Treatment for Gender-Dysphoric/Gender-Incongruent Persons.

The Endocrine Society and Pediatric Endocrine Society state the following in their guidelines:

  • There is a biological foundation to gender identity that should be considered when evaluating new policies.
  • Medical interventions for transgender patients are considered effective and generally safe, and should be covered by private and federal insurers.
  • National research programs should be prioritized and receive increased funding to educate others about transgender medical care.